We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information
Medications are available that can slow the progression of melanoma. However, not all melanomas respond, and the side effects sometimes outweigh the benefits.
That’s why researchers are working hard to develop more options—like those under investigation in our clinical research program.
On this page you’ll find information about melanoma clinical trials in general, the current treatment landscape, and active clinical trials for melanoma, including stage III (stage 3) melanoma and stage IV (stage 4) melanoma (also called advanced or metastatic melanoma).
Watch our short video to find out more about melanoma and why we are conducting clinical research into the condition.
Clinical trials in detail
Our "Participant's Discussion Guide to Cancer Clinical Trials" has information about how clinical trials work.
Download the guideDiscussing melanoma with your doctor
Topics you might want to discuss with your doctor,
Download discussion guideA Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma
View Trial DetailsA Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma
View Trial DetailsA Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)
A Study to Compare Nivolumab Drug Product Process D to Nivolumab Drug Product Process C in Participants With Stage IIIa/b/c/d or Stage IV Melanoma After Complete Resection
Thank you for considering a melanoma clinical trial
An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors
View Trial DetailsPattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice
View Trial DetailsYervoy Pregnancy Surveillance Study
View Trial DetailsAn Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread
View Trial DetailsA Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma
View Trial DetailsA Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma
View Trial DetailsA Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)
A Study to Compare Nivolumab Drug Product Process D to Nivolumab Drug Product Process C in Participants With Stage IIIa/b/c/d or Stage IV Melanoma After Complete Resection
Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma
View Trial DetailsA Study Evaluating the Drug Levels of Iplimumab Given Under the Skin Alone and in Combination With Nivolumab in Multiple Tumor Types
View Trial DetailsWe strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information